Growth Funding Genesis has secured funding and growth debt totaling around 32 million USD, plus a recent expansion trajectory evidenced by UK and Ireland engagement and a new AI design Partner Program. This indicates readiness for scale and potential budget for platform expansions, integrations, and enterprise deployments in hospital networks.

Strategic NHS Win Successful engagement with NHS National Services Scotland for an eight-year initiative to deploy complete clinical traceability signals a proven reference within large public health systems. This creates a compelling case study for hospital networks seeking compliance, traceability, and cost control across theatres and care sites.

AI and Design Partner Launch of Agentic AI Design Partner Program and Surgical Procedure Cost Savings Agent demonstrates a commitment to AI-enabled spend management and supplier optimization. This opens opportunities to collaborate with hospitals on co-developing AI workflows, procurement acceleration, and surgical supply chain reductions.

Regional Expansion Active regional focus in the U S United Kingdom and Ireland with events like AHRMM26 and partner programs suggests appetite for cross-border deployments and multi-market contracts, including integration with common healthcare tech stacks like EDI, ERP, and procurement platforms.

Ops and Platform Fit Core offering centers on clinical lifecycle management across operating theatres, cath labs, and patient bedside, aligning with hospital needs for data-driven cost control, patient protection, and proactive margins. This positions Genesis well for hospitals seeking end-to-end visibility and interoperability with existing systems (AWS, Salesforce, HubSpot, Microsoft 365, etc.).